Insider Selling: Trupanion (NASDAQ:TRUP) CEO Sells $25,840.00 in Stock

Posted by Francis Steltz on Oct 16th, 2026

Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 1,000 shares of the firm’s stock in a transaction dated Friday, October 9th. The shares were sold at an average price of $25.84, for a total value of $25,840.00. Following the transaction, the chief executive officer directly owned 184,952 shares in the company, valued at $4,779,159.68. This trade represents a 0.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

On Friday, September 11th, Margaret Tooth sold 1,000 shares of Trupanion stock. The stock was sold at an average price of $25.00, for a total value of $25,000.00.
On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The shares were sold at an average price of $31.84, for a total value of $15,633.44.
On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total value of $28,410.90.

Trupanion Trading Up 4.2%

Shares of TRUP stock opened at $27.86 on Friday. The stock has a market capitalization of $1.22 billion, a PE ratio of 50.43, a P/E/G ratio of 1.60 and a beta of 1.44. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $46.98. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The business has a 50-day moving average of $27.03 and a 200 day moving average of $25.53.

Trupanion (NASDAQ:TRUP – Get Free Report) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter last year, the business earned $0.22 earnings per share. The business’s revenue was up 11.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Institutional Investors Weigh In On Trupanion

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. purchased a new position in shares of Trupanion during the second quarter valued at about $134,774,000. Polar Capital Holdings Plc boosted its position in Trupanion by 13.5% during the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock valued at $55,121,000 after acquiring an additional 175,000 shares in the last quarter. Greenlea Lane Capital Management LLC boosted its position in Trupanion by 1.6% during the 4th quarter. Greenlea Lane Capital Management LLC now owns 776,490 shares of the financial services provider’s stock valued at $29,017,000 after acquiring an additional 12,395 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Trupanion by 15.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider’s stock valued at $17,981,000 after acquiring an additional 95,064 shares in the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of Trupanion during the 2nd quarter worth approximately $14,262,000.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Stifel Nicolaus raised their target price on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Cantor Fitzgerald cut their target price on Trupanion from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 7th. Finally, Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $38.40.

View Our Latest Report on TRUP

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.

The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.

Founded in 2000, Trupanion is headquartered in Seattle, Washington.